MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade

oleh: Wei Wang, Dong Han, Qinbo Cai, Tao Shen, Bingning Dong, Michael T. Lewis, Runsheng Wang, Yanling Meng, Wolong Zhou, Ping Yi, Chad J. Creighton, David D. Moore, Feng Yang

Format: Article
Diterbitkan: Nature Portfolio 2022-01-01

Deskripsi

PI3K inhibitors have limited efficacy in triple negative breast cancer (TNBC). Here, the authors show that MAPK4 activates AKT independent of PI3K and thus promotes tumour growth in a subset of TNBC and that MAPK4 inhibition sensitizes to PI3K blockade in these tumours.’